Evaluarea eficacităţii şi toleranței preparatului Abactal (Firma Lek Pharmaceuticals DD) în tratamentul infecţiilor tractului urinar

Abstract

Summary UTI is one major problem in the medicine. In treatment of UTI multiple therapeutic schemes are folowed. 32 patients with acute and cronic UTI were treated using antibacterial monoterapy with Abactal (LEK Pharmaceuticals dd). Positive rezults were found in 28 patients. While no change from the prescristing condition was found in 4 (12%). Tolerance was found to be good in 84% patients. Adverse effect were found in 16% patients. This antibactherial preparation has opened a new perspective in the treatment of patients with urinary tract infection.